Neurode
Clinical-grade stimulation pads delivered monthly to ensure comfortable wear
About Neurode
Neurode is a company based in Sydney, Australia. Recent Funding lists it under Health and bio. It went through HAX (HAX 2021). Investors on record for it include Khosla Ventures, PsyMed Ventures, SOSV, SOSV HAX and 1 other. It was founded by Alex Masmej, Nathalie Gouailhardou, Alex Cohen and 1 other.
Funding rounds
Founders and team
- AMAlex Masmej Co-Founder & CEOsource: neurodelabs.com
NG
Nathalie Gouailhardou Co-founder & CEO@nathaliegou · source: neurodelabs.com- ACAlex Cohen Co-foundersource: neurodelabs.com
DS
Damian Sofrevski Founder
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Neurode: questions and answers
- Who invested in Neurode?
- Investors on record for Neurode: HAX, Khosla Ventures, PsyMed Ventures, SOSV, SOSV HAX and StreShi.
- Who founded Neurode?
- Neurode was founded by Alex Masmej (Co-Founder & CEO), Nathalie Gouailhardou (Co-founder & CEO), Alex Cohen and Damian Sofrevski.
- Where is Neurode based?
- Neurode is based in Sydney, Australia.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neurode (get a free API key).